» Articles » PMID: 25654556

Interplay Between FGF21 and Insulin Action in the Liver Regulates Metabolism

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2015 Feb 6
PMID 25654556
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

A comparative genomic study across 396 liver biopsies provides deep insight into FGF21 mode of action as a therapeutic agent in metabolic dysfunction-associated steatotic liver disease.

Tang S, Borlak J Clin Transl Med. 2025; 15(2):e70218.

PMID: 39962359 PMC: 11832436. DOI: 10.1002/ctm2.70218.


Toxicokinetics of recombinant human fibroblast growth factor 21 for injection in cynomolgus monkey for 3 months.

Lu C, Jin L, Bi J, Jin H, You X, Peng L Front Pharmacol. 2023; 14:1176136.

PMID: 37288111 PMC: 10242211. DOI: 10.3389/fphar.2023.1176136.


Inducible UCP1 silencing: A lentiviral RNA-interference approach to quantify the contribution of beige fat to energy homeostasis.

Khor N, Swarbrick M, Gunton J PLoS One. 2019; 14(11):e0223987.

PMID: 31751350 PMC: 6872148. DOI: 10.1371/journal.pone.0223987.


Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21.

Sawicki K, Chang H, Shapiro J, Bayeva M, De Jesus A, Finck B JCI Insight. 2018; 3(13).

PMID: 29997282 PMC: 6124529. DOI: 10.1172/jci.insight.95948.


Sex-specific association between fibroblast growth factor 21 and type 2 diabetes: a nested case-control study in Singapore Chinese men and women.

Wang Y, Koh W, Yuan J, Pan A Nutr Metab (Lond). 2017; 14:63.

PMID: 29021814 PMC: 5622539. DOI: 10.1186/s12986-017-0216-0.